Evidence map›Paper›PMID 42137464›Full record

ArticleOncology letters2026

Mutational landscape in the precancerous stages of sporadic colorectal cancer.

Anna Valickova, Marketa Urbanova, Josef Horak, Jiri Jungwirth, Jan Kral, Tomas Hucl, Veronika Makajevova, Sandra Summerova, Pavel Kohout, Radoslav Matej and 2 more

Abstract read
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna ValickovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of The Czech Academy of Sciences, 142 00 Prague, Czech Republic.
Marketa UrbanovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of The Czech Academy of Sciences, 142 00 Prague, Czech Republic.
Josef HorakDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of The Czech Academy of Sciences, 142 00 Prague, Czech Republic.
Jiri JungwirthInstitute of Physiology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.
Jan KralDepartment of Internal Medicine, Second Faculty of Medicine, Charles University, 150 06 Prague, Czech Republic.
Tomas HuclDepartment of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 142 00 Prague, Czech Republic.
Veronika MakajevovaDepartment of Surgery, Thomayer University Hospital, 142 00 Prague, Czech Republic.
Sandra SummerovaDepartment of Internal Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, 142 00 Prague, Czech Republic.
Pavel KohoutDepartment of Internal Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, 142 00 Prague, Czech Republic.
Radoslav MatejDepartment of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, 142 00 Prague, Czech Republic.
Pavel VodickaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of The Czech Academy of Sciences, 142 00 Prague, Czech Republic.
Veronika VymetalkovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine of The Czech Academy of Sciences, 142 00 Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal adenoma (CRA) is a precancerous lesion that can progress to colorectal carcinoma (CRC); however, its malignant potential varies considerably. The present study aimed to characterize the putatively pathogenic variants (PPVs) of CRA and to assess their potential clinical relevance in identifying lesions with an increased risk of progression at precancerous stages. PPVs in a panel of 176 cancer-associated genes were analyzed in 67 CRA samples and matched adjacent normal mucosa using next-generation sequencing. The panel included genes involved in DNA repair pathways, cell cycle regulation and the genes directly associated with CRC development. PPVs in CRA tissue were identified in 44 patients. The most frequently mutated genes were found to be

Indexed as

colorectal adenomamutationnext-generation sequencing

Identifiers

PMID42137464
PMCPMC13168841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.